tegafur has been researched along with uftoral in 271 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 111 (40.96) | 18.2507 |
| 2000's | 150 (55.35) | 29.6817 |
| 2010's | 10 (3.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuma, T; Ikeda, T; Kobayashi, F; Kurosaki, M; Marumo, F; Sakamoto, N; Sakamoto, S; Sato, C; Tozuka, S | 1 |
| Fujioka, A; Nakano, K; Nukatsuka, M; Saito, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Akao, S; Ishikawa, H; Iwami, N; Kiumi, F; Oya, M; Sasaki, K; Terada, H | 1 |
| Fujita, M; Honda, I; Jingu, K; Satomi, D; Tsurumachi, T; Watanabe, K; Watanabe, S; Yamada, S; Yamamoto, H | 1 |
| Fujioka, A; Nukatsuka, M; Saito, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Matsumoto, K; Onodera, H; Otawa, K; Sato, T; Ukai, K | 1 |
| Inada, T; Kase, S; Kitajima, M; Kubota, T; Kumai, K; Kurihara, N; Watanabe, M | 1 |
| Kikuchi, H; Nasu, M; Ogata, M; Ohtsuka, E; Uno, N | 1 |
| Amano, T; Hayashi, Y; Imada, T; Kubo, A; Maehara, T; Matsumoto, A; Morohoshi, T | 1 |
| Fujita, H; Fujita, K; Fukuda, Y; Fukushima, M; Ishioka, T; Ito, H; Kishibe, S; Kogawa, R; Koie, H; Kudo, T; Machida, S; Maruyama, A; Sato, T; Takashima, K; Tsuge, T; Tsushima, T; Yagihashi, N | 1 |
| Iijima, K; Iwazaki, R; Maehiro, K; Miwa, H; Mizobuchi, N; Okura, R; Ono, Y; Ota, K; Sato, K; Sato, N; Urabe, M; Wada, R | 1 |
| Dohi, K; Goto, T; Haruta, R; Kataoka, T | 1 |
| Ichikura, T; Okusa, Y; Tamakuma, S; Tomimatsu, S; Uefuji, K; Yahara, T | 1 |
| Ikeda, E; Isomoto, H; Kato, T; Kodaira, S; Okuda, M; Takahashi, T; Teramoto, T; Yamamoto, Y | 1 |
| Hyakuna, Y; Kushibiki, K; Matsuoka, H; Shimada, M; Yokomichi, H | 1 |
| Horiuchi, N; Tamura, R; Yokoi, K | 1 |
| Fujioka, A; Fujita, K; Satake, H; Takeda, S; Uchida, J; Unemi, N | 1 |
| Fujii, K; Fukuda, T; Hoshino, T; Ishii, T; Komatsu, M; Masamune, O; Mikami, K; Ohshima, S; Ono, T | 1 |
| Boku, N; Ishii, H; Kaneko, K; Kusada, O; Muro, K; Muto, M; Ohkuwa, M; Ohtsu, A; Sasaki, Y; Tajiri, H; Yoshida, S | 1 |
| Fujii, M; Imanishi, Y; Kanke, M; Ohno, Y; Tokumaru, Y | 1 |
| Kobayashi, K | 1 |
| Aoki, T; Inoue, Y; Kashimura, H; Nimura, H; Ogata, N; Ohtani, M; Sano, Y; Sekine, C; Takayama, S; Tsutsumi, J | 1 |
| De Guzman, LM; Fernando, GY; Guancia, AA; Romana, IB; Samson, MC; Villalon, AH | 1 |
| Rustum, YM | 1 |
| Taguchi, T | 5 |
| Pazdur, R | 3 |
| Blanco, E; Colmenarejo, A; Crespo, MC; de Castro, J; Espinosa, E; Espinosa, J; Feliu, J; Garcia Girón, C; González Barón, M; Juárez, F; Martinez, B; Ordóñez, A | 1 |
| Belón, J; Blanco, E; Espinosa, E; Feliu, J; Garcia Alfonso, P; Garcia Girón, C; Garrido, P; González Barón, M; Jara, C; Ruiz, A; Vincent, JM; Zamora, P | 1 |
| Fukushima, M; Nakano, K; Saito, H; Satake, H; Takechi, T; Takeda, S; Uchida, J; Unemi, N | 1 |
| Asano, M; Mori, T; Takahashi, K; Yasuno, M | 1 |
| Kouchi, Y; Maeda, Y; Morinaga, H; Ohuchida, A | 1 |
| Hamaguchi, K; Kamura, K; Matsushita, K; Seto, K; Shiomi, K; Yamauchi, T | 1 |
| Aiura, K; Arisawa, Y; Ishii, S; Kakefuda, T; Kitagawa, Y; Kogure, A; Nakagawa, M; Noga, K; Shirasugi, N | 1 |
| Fujimaki, M; Katuyama, S; Kuroki, Y; Okamoto, M; Sakamoto, T; Tazawa, K; Yamashita, I | 1 |
| Chida, E; Fujii, M; Fukuda, S; Furuta, Y; Inuyama, Y; Kanzaki, J; Nagahashi, T; Shirato, H; Yagi, K | 1 |
| Bready, B; Diaz-Canton, E; Ho, DH; Lassere, Y; Pazdur, R | 1 |
| Fuchino, Y; Ikeda, S; Kimura, H; Mitsuishi, K; Tanaka, S; Tomita, A; Umeno, T | 1 |
| Hioki, M; Hirano, S; Hirata, T; Hisayoshi, T; Kutsukata, N; Masuda, S; Yamagishi, S; Yamamoto, S; Yamashita, Y | 1 |
| Tsukagoshi, S | 1 |
| Inaji, H; Koyama, H; Motomura, K; Noguchi, S | 1 |
| Hitomi, S; Otake, Y; Tanaka, F; Wada, H | 1 |
| Hata, K; Kaganoi, J; Nanbu, H; Nishitai, R; Ohsumi, K; Tokunaga, Y | 1 |
| Baba, H; Kakeji, Y; Maehara, Y; Ohno, S; Sugimachi, K | 1 |
| Birkhofer, MJ; Meropol, NJ; Noel, D; Sonnichsen, DS | 1 |
| DeMario, MD; Ratain, MJ | 1 |
| Kodaira, S | 1 |
| Jones, J; Mamounas, EP; Wickerham, DL; Wieand, HS; Wolmark, N | 1 |
| Skillings, JR | 1 |
| Carmichael, J | 1 |
| Abad, A; Aranda, E; Diaz-Rubio, E; Fernandez-Martos, C; Gallén, M; Marcuello, E; Martín, C; Navarro, M; Sastre, J | 1 |
| Diaz-Canton, E; Pazdur, R | 1 |
| Minsky, BD | 1 |
| Codes, M; Dugue, A; Garcia, E; Iglesias, L; Moreno, JA; Murillo, E; Torrija, E; Virizuela, JA | 1 |
| Ayala, F; Casado, A; Diaz-Rubio, E; López-Martin, JA; Martin, M; Nieto, Y; Rodriguez-Lescure, A | 1 |
| Colevas, AD | 1 |
| Diaz-Rubio, E; Garcia Carbonero, I; González-Larriba, JL; Perez Segura, P; Sastre Valera, J | 1 |
| Hitomi, S; Tanaka, F; Wada, H | 1 |
| Ichinose, Y; Kuba, M; Kudoh, S; Morikawa, T; Niitani, H; Yano, T; Yoshimori, K | 1 |
| Kurihara, M | 1 |
| Belón, J; de Castro, J; Espinosa, E; Feliu, J; García Alfonso, P; García Girón, C; Garrido, P; González Barón, M; Lomas, M; Ordóñez, A; Zamora, P | 1 |
| Hanauske, AR | 1 |
| Kim, BS; Kim, JG; Kim, JS; Kim, YH; Park, YT; Shin, SW | 1 |
| Mani, S | 1 |
| Arikian, S; de Andrade, CA; Delfino, C; Doyle, J; Murad, A; Sinha, N | 1 |
| Koinumaru, S; Matsuda, T; Nakai, Y; Saitoh, J | 1 |
| Baba, K; Fukuda, M; Higuchi, A; Masuyama, S; Matsuda, M; Matsumoto, H; Matsuoka, Y; Miyayama, H; Nagao, K; Nishimura, R; Uchino, S; Yamashita, H | 1 |
| Watanabe, T | 1 |
| Abe, T; Aiba, K; Furue, H; Hasegawa, K; Horikoshi, N; Kanamaru, R; Kurihara, M; Niitani, H; Ogawa, M; Taguchi, T; Takeda, S | 1 |
| Amano, T; Hatori, S; Imada, T; Ito, H; Kondo, J; Maehara, T; Rino, Y; Shiozawa, M; Suzuki, Y; Takahashi, M | 1 |
| Ebuchi, M; Kudo, T; Kuwabara, H; Maruyama, M; Sugano, N; Yoshida, T | 1 |
| Bandai, Y; Gunji, A; Haga, S; Hiraishi, M; Idezuki, Y; Konishi, T; Murata, N; Nishigaki, M; Shibusawa, M; Shinohara, K; Ushirokouji, Y; Watanabe, H; Yabe, K; Yamamura, T; Yumoto, S | 1 |
| Danjo, Y; Takayanagi, N | 1 |
| Hosokawa, M; Kobayashi, M; Kuramitsu, Y; Li, YQ; Matsushita, K; Obara, M; Ohiro, Y | 1 |
| Ando, A; Asano, N; Bamba, T; Fujiyama, Y; Fukano, M; Inoue, T; Ito, A; Koyama, S; Kubo, M; Sasaki, M; Sato, J; Tsujikawa, T; Yoshioka, U | 1 |
| Fujiwara, Y; Hisa, N; Kume, M; Ogoshi, S; Tanaka, Y; Yoshida, S | 1 |
| Ando, E; Fukuda, H; Fukumori, K; Kato, O; Kusaba, T; Sata, M; Tanaka, M; Tanikawa, K; Yamamoto, H; Yamashita, F; Yano, Y | 1 |
| Akaza, H; Hattori, K; Ishikawa, S; Kawai, K; Kikuchi, K; Kobayashi, T; Koiso, K; Kondo, F; Manabe, F; Matsuki, K; Miyanaga, N; Noguchi, R; Shimazui, T; Suzuki, R; Takeshima, H; Tsuchiya, A; Uchida, K | 1 |
| Kazumori, H; Moritani, M; Sizuku, T; Uchida, Y; Yamamoto, S | 1 |
| Ajani, JA; Takiuchi, H | 2 |
| Chimori, Y; Ikoma, H; Miyamoto, Y; Nanri, M; Nishioka, B; Oguro, A; Yamane, E | 1 |
| Fukuse, T; Hitomi, S; Miyahara, R; Ohtake, Y; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Abe, O; Demura, H; Endo, M; Kawamura, E; Kimura, K; Kubota, T; Nakao, I; Saito, T; Sasano, H; Sasano, N | 1 |
| Chan, KK; Groshen, S; Jeffers, S; Leichman, CG; Leichman, L; Muggia, FM; Spicer, D; Wu, X | 1 |
| Kimura, S; Naito, Y; Nakajima, T; Ohtake, K; Saku, T; Yoshizawa, M | 1 |
| Benner, SE; Canetta, R; Hoff, PM; Pazdur, R | 1 |
| Goto, R; Ikeuchi, T; Kai, Y; Ota, M; Yoshikawa, H | 1 |
| Meropol, NJ | 1 |
| Birkhofer, MJ; Ferreira, I; Meropol, NJ; Noel, D; Sonnichsen, DS | 1 |
| Hara, S; Ikeda, Y; Koseki, S; Morozumi, K; Shibata, S; Yamauchi, T | 1 |
| Akaza, H; Tsukamoto, S | 1 |
| Kawabata, Y; Nio, Y; Ohishi, T; Sumi, S; Tamura, K; Yano, S | 1 |
| Hashimoto, Y; Iwasaki, K; Oida, I; Ozawa, T; Usami, A; Yamada, M | 1 |
| Kasai, N; Mutoh, Y | 1 |
| Ashida, H; Iida, S; Kimura, J; Matsumoto, T; Tanaka, A; Teramura, C | 1 |
| Benner, S; DeMario, MD; Fleming, GF; Johnson, S; Lebwohl, D; Mani, S; Melton, K; Ratain, MJ; Vogelzang, NJ; Vokes, EE | 1 |
| Choi, S; Habelhah, H; Hosokawa, M; Kobayashi, M; Konishi, Y; Nakae, D; Okada, F; Totsuka, Y | 1 |
| Haga, S; Hirai, M; Kajiwara, T; Naritaka, Y; Ogawa, K; Otani, Y | 1 |
| Cao, S; Rustum, YM | 1 |
| Brito, R; Hoff, PM; Medgyesy, D; Pazdur, R; Royce, M | 1 |
| Bekradda, M; Cvitkovic, E | 1 |
| Langer, CJ | 2 |
| Hoff, PM; Lassere, Y; Pazdur, R | 1 |
| Laohavinij, S; Maoleekoonpairoj, S; Thavichaigarn, P; Thongprasert, S | 1 |
| Chazard, M; Coudray, AM; de Gramont, A; Gespach, C; Louvet, C; Prévost, S; Raymond, E; Tournigand, C | 1 |
| Aoyagi, S; Hisamatsu, T; Ikezawa, T; Matsuoka, K; Mizuno, Y; Motohashi, Y; Nishida, J; Tatsuno, S | 1 |
| Haseme, E; Kikuchi, K; Ohnishi, Y; Shohkei, O | 1 |
| de Bono, JS; Twelves, CJ | 1 |
| Alberts, D; Brooks, D; Damle, B; Ferreira, I; Kaul, S; Pazdur, R; Ravandi, F; Sonnichsen, D; Stewart, D | 1 |
| Akagi, Y; Kobayashi, H; Matono, K; Miyagi, Y; Nakagawa, M; Nozoe, Y; Ogata, Y; Sasatomi, T; Shirouzu, K | 1 |
| Iwase, H; Kameya, T; Makuuchi, H; Sadahiro, S; Suzuki, T; Tajima, T | 1 |
| Chang, W; Kondo, Y; Maeda, S; Matsusaka, S; Okada, T; Oriyama, T; Satake, M; Son, G | 1 |
| Borner, M; Maroun, J; Scheithauer, W; Twelves, C; Wilke, H | 1 |
| Aguayo, A; Patt, YZ | 1 |
| Akamo, Y; Hasegawa, M; Manabe, T; Takeyama, H; Teranishi, F | 1 |
| Higashigawa, M; Kagawa, Y; Kakito, H; Kawasaki, H; Kojima, M; Ohkubo, T; Ooi, A; Sakurai, M | 1 |
| Ishihama, H | 1 |
| Fujisawa, A; Ikeda, H; Inokuchi, T; Kitamura, A; Nonaka, M; Ohba, S; Tobita, T; Uehara, M | 1 |
| Aoyagi, H; Fukue, M; Ikezawa, K; Kodaira, Y; Maruyama, T; Matsui, S; Monma, E; Nozue, M; Sakamoto, T; Shidara, S; Shimakura, S; Takada, Y; Yoshida, T | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Kitazato, K; Miyadera, K; Okabe, S; Yonekura, K | 1 |
| Fujioka, A; Fukushima, M; Nakagawa, F; Nukatsuka, M; Ohshimo, H | 1 |
| Hatano, T; Hokama, S; Ogawa, Y; Touyama, H | 1 |
| Koyama, S; Shimoda, S; Takeda, N; Tanaka, N; Tsukahara, A; Yajima, K | 1 |
| Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K | 1 |
| Baba, S; Hasumi, A; Kato, T; Koike, A; Manabe, T; Maruta, M; Miura, K; Nakazato, H; Nimura, Y; Ohashi, Y; Saji, S; Suzuki, H; Takagi, H; Yamaguchi, A | 1 |
| Ioka, Z; Nakane, Y; Nakano, K; Osaka, Y; Sako, H; Takemura, N; Tanabe, S; Tsuchiya, K | 1 |
| Daijo, H; Hoshino, T; Inokuma, S; Ishida, H; Nakada, H; Ohsawa, T; Takeuchi, I | 1 |
| Chun, H; Im, YH; Jung, CW; Kang, WK; Kim, JH; Kim, K; Kim, WS; Lee, HR; Lee, JY; Lee, MH; Lee, NS; Lee, WY; Nam, E; Oh, SY; Park, CH; Park, JO; Park, K; Park, SH; Song, SY | 1 |
| Ayabe, H; Fukuoka, H; Hidaka, S; Nakagoe, T; Nanashima, A; Sawai, T; Shibasaki, S; Tanaka, K; Tsuji, T; Yamaguchi, H; Yamashita, H; Yasutake, T | 1 |
| Fukushimab, M; Matsuoka, K; Miyahara, R; Nakagawa, T; Otake, Y; Takata, T; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Fujii, M | 1 |
| Ito, T; Nakamura, A; Sato, A; Taguchi, S; Tomita, T | 1 |
| Shimizu, Y | 1 |
| Asoh, H; Fukuyama, Y; Ichinose, Y; Ikeda, J; Teruya, T; Ushijima, C; Yamaguchi, M | 1 |
| Hasebe, K; Sasaki, S; Takamura, H; Urade, M; Yagi, M | 1 |
| Azuma, T; Hatada, T; Inoue, Y; Kusunoki, M; Miki, C; Mohri, T; Ojima, E | 1 |
| Chen, JS; Hsu, KC; Tang, R; Wang, JY; Yang, TS | 1 |
| Hanaoka, N; Tanaka, F; Wada, H | 1 |
| Asaoka, T; Imasato, M; Iwazawa, T; Kanoh, T; Kinuta, M; Matsui, S; Monden, T; Nakano, Y; Okada, K; Okamura, J; Tono, T; Yano, H | 1 |
| Ito, T; Kamachi, H; Kamiyama, T; Kondo, M; Kurauchi, N; Matsushita, M; Nakagawa, T; Nishikawa, M; Ogata, T; Todo, S | 1 |
| Arai, Y; Ichikawa, Y; Inoue, H; Kamoi, K; Koide, T; Miki, T; Miura, H; Nakai, Y; Nishimura, K; Nonomura, N; Okuyama, A; Shimizu, K; Sugao, H; Takaha, N; Takatera, H; Tokizane, T; Uchida, K; Ukimura, O; Yamaguchi, S | 1 |
| Kido, S; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Motoyama, K; Takei, M | 1 |
| Azegami, T; Fujimori, S; Kobayashi, H; Koike, T; Kurashina, K; Kurita, H; Ohtsuka, A; Tanaka, K | 1 |
| Ikeda, H; Inokuchi, T; Irie, A; Mizoguchi, Y; Shibahara, K; Takebe, Y; Yamada, K | 1 |
| Hoff, PM | 1 |
| Hitsuda, Y; Kawasaki, Y; Koshohbu, T; Matsumoto, S; Nakatani, S; Shimizu, E; Yasuda, K | 1 |
| Fujimura, Y; Miyayama, H; Nagao, K; Nakagawa, K; Nishimura, R; Okazaki, S | 1 |
| Hidaka, H; Koga, T; Nomiyama, H; Yano, T | 1 |
| Hata, K; Hiraga, T; Ikeda, F; Tamura, D; Ueda, A; Williams, PJ; Yoneda, T | 1 |
| Akiyama, N; Arai, F; Funakoshi, K; Inayoshi, J; Kato, T; Kozakai, I; Motoyama, H; Ohta, T; Saito, Y; Takii, Y | 1 |
| Hirayama, R; Ichikawa, W; Nihei, Z; Sasaki, Y; Shirota, Y; Sugihara, K; Takahashi, T; Uetake, H; Yamada, H | 1 |
| Chin, K; Furuta, N; Hatake, K; Itoh, Y; Mishima, Y; Mizunuma, N; Nagasaki, E; Shinozaki, E; Takahashi, S; Terui, Y; Tokutome, N; Usui, N | 1 |
| Hashimoto, D; Hoshino, T; Inokuma, S; Ishida, H; Itoyama, S; Matsumoto, Y; Miura, T; Mori, T; Murata, N; Nakada, H; Odaka, A; Ohsawa, T; Okada, N; Shirakawa, K; Suzuki, T; Takeuchi, I; Yamada, H; Yokoyama, M | 1 |
| Ebuchi, M; Hasegawa, K; Kato, K; Maruyama, M; Nagahama, T; Shinoura, H; Takashima, I | 1 |
| Arai, K; Iwasaki, Y; Katayanagi, S; Matsumoto, H; Miyamoto, H; Takahashi, K; Yamaguchi, T | 1 |
| Handa, R; Iijima, S; Kato, T; Kikkawa, N; Kurokawa, E; Naoi, Y; Oshima, S; Tsujie, M; Yamamoto, H | 1 |
| Handa, R; Iijima, S; Kato, T; Kikkawa, N; Kurokawa, E; Naoi, Y; Ohshima, S; Tsujie, M; Yamamoto, H | 1 |
| Enomoto, M; Higuchi, T; Sugihara, K; Uetake, H | 1 |
| Imamura, M; Yamaki, T; Yasuda, M | 1 |
| Dono, K; Maruhashi, S; Miyamoto, A; Monden, M; Nagano, H; Nakamori, S; Sakon, M; Takahashi, Y; Tujie, M; Umeshita, K | 1 |
| Hirano, T; Kitahara, K; Magata, S; Matsuyama, S; Miyazaki, K; Mori, M; Shimonishi, T | 1 |
| Funahashi, K; Goto, T; Koike, J; Matsumoto, H; Miki, T; Ryu, M; Saito, N; Shiokawa, H; Teramoto, T; Tokuyama, T | 1 |
| Adachi, M; Ishida, S; Katsuragi, A; Nakayama, A; Suzuki, M; Takeuchi, S | 1 |
| Aoki, H; Aoki, N; Hayashi, S; Hemmi, A; Karube, H; Masuda, H; Nakayama, H; Ogame, H; Sakamoto, N; Wakabayashi, K | 1 |
| Akay, S; Doganavsargil, B; Ozütemiz, O | 1 |
| Aoki, T; Hayashida, Y; Kataba, Y; Kawakita, H; Kinoshita, M; Kubouchi, T; Saito, H; Sato, S; Takagi, M; Tamura, K; Tsuchida, A | 1 |
| Aihara, T; Fukuhara, A; Kouno, T; Murayama, M; Nakagawa, K; Nakamura, E; Niida, M; Nishimoto, Y; Nozaki, H; Syouda, S; Watanabe, Y; Yagyu, T; Yasuoka, H | 1 |
| Miyahara, R; Otake, Y; Tanaka, F; Wada, H; Yanagihara, K | 1 |
| Hojyo, K; Isomoto, H; Kato, T; Kodaira, S; Kunii, Y; Kunitomo, K; Niimoto, M; Nishida, O; Ohashi, Y; Takahashi, T; Tominaga, T; Watanabe, M; Yasutomi, M | 1 |
| Haga, S; Imamura, H; Kinoshita, J; Ogawa, K; Okabe, T; Shimizu, T; Watanabe, O | 1 |
| Ito, S; Mitsuhata, N; Watanabe, Y | 1 |
| Anazawa, S; Hirai, K; Kawahara, H; Ogawa, M; Sakuyama, T; Sato, K; Takao, Y; Yamazaki, Y; Yokoyama, M | 1 |
| Hashimoto, D; Inokuma, S; Ishida, H; Nakada, H; Ohsawa, T; Shirakawa, K; Yamada, H; Yokoyama, M | 1 |
| Fujihara, M; Fujita, M; Furukawa, Y; Hattori, Y; Ishii, Y; Kuniki, H; Matsumoto, N; Yajima, T; Yamamoto, M; Yamaoka, Y | 1 |
| Ikemura, K; Oya, R | 1 |
| Hashimoto, K; Higami, T; Itakura, M; Koike, M; Nio, Y; Yano, S | 1 |
| Baba, Y; Ishikawa, T; Kamimura, T; Mizuno, K; Oota, H; Watanabe, K; Yoshida, T | 1 |
| Ebisui, C; Fujimoto, T; Fukuchi, N; Hasuike, Y; Hayashi, N; Izawa, H; Izumiyama, K; Koshino, T; Sakita, I; Soma, I; Yoshida, T | 1 |
| Itoh, S; Mitsuhata, N; Watanabe, Y | 1 |
| Inada, K; Ishikawa, T; Kamoshida, S; Maeda, K; Matsuoka, H; Shimomura, R; Tsutsumi, Y | 1 |
| Enomoto, M; Higuchi, T; Iida, S; Sugihara, K; Tsunozaki, H; Uetake, H; Yasuno, M | 1 |
| Fukai, H; Maruyama, A; Matsumoto, H; Sakamoto, H; Takami, M; Takimoto, T; Togo, Y; Yamamoto, T | 1 |
| Byun, JH; Choi, MG; Chung, IS; Hong, YS; Kang, JH; Kim, KW; Lee, KS; Lee, MA; Moon, DH; Park, SY; Shim, BY; Woo, IS | 1 |
| Fleming, GF; Gupta, S; Mauer, AM; Ryan, CW; Samuels, BL; Taber, DA | 1 |
| Choi, CW; Choi, IK; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, JH; Shin, SW; Yoon, SY | 1 |
| Chan, WK; Chao, Y; Chen, WS; Chi, KH; Jiang, JK; Lee, RC; Li, AF; Lin, JK; Lin, TC; Wang, HS; Wang, LW; Yang, SH; Yen, SH | 1 |
| Endo, Y; Fukushima, T; Kanazawa, M; Ohki, S; Ohshima, T; Saito, M; Sekikawa, K; Takenoshita, S | 1 |
| Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Fukushima, M; Ishikawa, S; Miyahara, R; Nakagawa, T; Tanaka, F; Wada, H | 1 |
| Beauchamp, RD; Berlin, J; Blanke, CD; Caillouette, C; Chakravarthy, B; Choy, H; Leach, S; Roberts, J; Shyr, Y; Tarpley, J; Tedesco, KL; Teng, M; Wyman, K | 1 |
| Johnstone, P; Kauh, J | 1 |
| Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T | 2 |
| Arima, T; Horino, K; Inoue, M; Kaneda, H; Kimura, M; Kume, S; Matsushita, H; Morisaki, T; Nishimura, T; Uemura, K | 1 |
| Hirakawa, K; Ishikawa, T; Kato, Y; Nakata, B; Ogawa, Y; Onoda, N; Takagaki, K; Takashima, T | 1 |
| Ichinose, Y; Okamoto, T | 2 |
| Hatakeyama, K; Muneoka, K; Okumura, S; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Furuse, J; Ikeda, M; Ishii, H; Morizane, C; Okusaka, T; Ueno, H | 1 |
| Amano, T; Hiki, Y; Kumada, K; Mitomi, T; Nishiyama, K; Noto, T; Ogawa, N; Oka, H; Oki, S; Otani, Y; Sadahiro, S; Takahashi, T; Takemiya, S; Tsuchiya, S; Yamakawa, T; Yamamura, T | 1 |
| Fujii, H; Hasegawa, S; Hatano, E; Ikai, I; Kawashima, K; Matsumoto, S; Satoh, S; Shimahara, Y | 1 |
| Akasaka, Y; Hata, Y; Honda, S; Ito, T; Matsuoka, S; Nakajima, N; Ohmori, K; Sano, F; Yokoyama, R | 1 |
| Hamada, T; Ichimura, W; Minagawa, N; Mino, K; Naito, H; Orimo, T; Shibazaki, W; Shinohara, T | 1 |
| Fujii, Y; Kobayashi, T; Kuga, T; Matsuoka, T; Morikage, N; Nakayama, T | 1 |
| Fukasawa, M; Kano, N; Kitagawa, M; Kitahama, S; Koneri, K; Kuroki, M; Kusanagi, H; Takeshi, A; Watanabe, Y; Yamamoto, S | 1 |
| Ichimori, T; Ishikawa, M; Ishikura, H; Kimura, S; Okitsu, H; Sakata, A; Seike, J; Yuasa, Y | 1 |
| Fukuda, S; Hazama, S; Kudoh, A; Mizuta, E; Ogura, Y; Oka, M; Sano, A; Shimizu, R; Yoshino, S | 1 |
| Fujiwara, H; Hamabe, Y; Ishida, T; Kaji, M; Mukai, H; Mukubou, H; Onishi, N; Sato, S; Toyokawa, A; Tsujimura, T; Tsukamoto, T; Wakahara, T; Wakita, K; Watanabe, A | 1 |
| Ito, T; Iwase, K; Kainuma, S; Kanou, T; Mizuno, H; Mizushima, T; Nakamori, Y; Ozawa, H; Souma, Y; Yamanaka, H | 1 |
| Tanaka, F; Wada, H | 1 |
| Akasu, T | 1 |
| Maeda, Y; Makuuchi, H; Murayama, C; Sadahiro, S; Suzuki, T | 1 |
| Endo, Y; Mitsuya, T; Sanada, Y; Tajiri, T; Uyama, R; Yoshizawa, Y | 1 |
| Hasuo, T; Ikeshima, S; Ishihara, K; Iwatsuki, M; Kuramoto, M | 1 |
| Fujii, K; Iizuka, R; Ikawa, O; Izumi, H; Kakihara, N; Katoh, Y; Matsumura, H; Miyata, K; Ohgaki, M; Shimomura, K; Shimotsuma, M; Tkenaka, A | 1 |
| Ishigame, T; Ishii, Y; Okayama, H; Takahashi, M | 1 |
| Hatakeyama, K; Muneoka, K; Sakata, J; Shirai, Y; Wakai, T; Yokoyama, N | 1 |
| Akita, H; Ishida, H; Kabuto, T; Nakaguchi, K; Watanabe, Y | 1 |
| Morimoto, N; Shibaki, T | 1 |
| Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T | 1 |
| Arai, Y; Inaba, Y; Kanemitsu, Y; Muro, K; Nishiofuku, H; Oyama, T; Sato, Y; Sawaki, A; Shimamoto, H; Yamaura, H | 1 |
| Iwamoto, S; Yoshioka, K | 1 |
| Kobayashi, H; Koike, T; Kurashina, K; Kurita, H; Miyazawa, H; Uehara, S | 1 |
| Hoki, M; Ito, T; Iwamoto, T; Iwase, K; Kanou, T; Mizuno, H; Mizushima, T; Nakamori, Y; Ozawa, H; Souma, Y | 1 |
| Arai, K; Hashimoto, T; Hiruma, K; Iwasaki, Y; Matsumoto, H; Saze, Z; Takahashi, K; Yamaguchi, T; Yamashita, Y; Yasutome, M | 1 |
| Dono, K; Hayashi, N; Monden, M; Nagano, H; Nakahira, S; Nakamori, S; Okami, J; Sakon, M; Takahashi, Y; Takeda, S; Tsujie, M; Umeshita, K | 1 |
| Afchain, P; André, T; de Gramont, A; Segura, C | 1 |
| Aoki, M; Ebina, A; Hoshi, Y; Ishiguro, A; Mitobe, S; Munakata, M; Okada, R; Sakata, Y; Shitara, K; Tomioka, R | 1 |
| Machida, H; Suzuki, K; Toda, H; Ushida, S | 1 |
| Ando, T; Goto, H; Ina, K; Inagaki, J; Ito, A; Kataoka, T; Kato, H; Nagao, S; Niwa, Y; Ohkita, T | 1 |
| Aikou, T; Haraguchi, Y; Ikeda, N; Kamikado, C; Sakamoto, F; Toyoyama, H; Ueno, S | 1 |
| Fuji, K; Hirazuka, T; Ikeda, T; Kahno, T; Mashino, K; Ninomiya, M; Shibahara, K; Yamamoto, M | 1 |
| Gega, M; Hashimoto, A; Ikeuchi, H; Kuno, T; Noda, M; Oshima, T; Tanaka, K; Tsukamoto, K; Yagyuu, T; Yamamura, T; Yanagi, H; Yoshikawa, R | 1 |
| Shoji, Y; Toyooka, M | 1 |
| Ao, T; Baba, S; Hirayama, T; Irie, A; Iwabuchi, K; Iwamura, M; Kudoh, O; Matsumoto, K; Uchida, T | 1 |
| Maeda, Y; Sasaki, E; Sasaki, T | 1 |
| Aoki, T; Mino, A; Murahashi, K; Nishino, K; Sowa, M; Tachimori, A; Takagaki, K | 1 |
| Komatsu, Y | 1 |
| Cho, H; Hasegawa, S; Kobayashi, O; Osaragi, T; Sairenji, M; Tsuburaya, A; Yoshida, T; Yoshikawa, T | 1 |
| Honda, J; Miyoshi, T; Seike, J; Tangoku, A; Umemoto, A; Yoshida, T | 1 |
| Furukawa, T; Ishii, H; Maruyama, M; Ohata, M; Ohori, M; Saito, N; Sato, H; Tokura, Y | 1 |
| Hoshi, K; Ikeda, Y; Kanbara, T; Kawasaki, Y; Namima, T; Ohnuma, T | 1 |
| Kerbel, RS; Man, S; Munoz, R | 1 |
| Isogai, A; Kubota, S; Matsuoka, H; Nagaya, M; Tsukikawa, S; Watanabe, T | 1 |
| Geboes, K; Van Cutsem, E | 1 |
| Emi, Y; Fukui, Y; Kakeji, Y; Maehara, Y; Oki, E; Sumiyoshi, Y | 1 |
| Baatrup, G; Bisgaard, C; Hansen, F; Jacobsen, A; Pfeiffer, P; Qvortrup, C; Rasmussen, P; Vestermark, LW | 1 |
| Fujimoto, K; Hirao, Y; Okajima, E; Ozono, S; Tsujimoto, S | 1 |
| Abbruzzese, JL; Anthony, L; Hoff, PM; Kopetz, S; Langleben, A; Lassere, Y; Rinaldi, D; Thomas, MB; Wolff, RA | 1 |
| Hoshino, S; Maekawa, T; Mikami, K; Sakai, T; Shirakusa, T; Yamashita, Y | 1 |
| Aerts, JG; Gras, J; Hoogsteden, H; Pouw, E; Pronk, T; Salomé, J; Schmitz, PI; Surmont, V; Tan, KY; van Klaveren, RJ; Vernhout, R | 1 |
| Fukushima, M; Tanaka, F; Wada, H | 1 |
| Matsui, N; Nakao, K; Tsunoda, A; Tsunoda, Y; Watanabe, M | 1 |
| Akagi, J; Baba, H | 1 |
| Arita, M; Kuga, Y; Miwata, T; Moriya, T; Murakami, E; Nishida, T; Numata, Y; Ohya, T; Okanobu, H; Tanaka, T; Yoshimi, S | 1 |
| Kawai, K; Kitayama, J; Nagawa, H; Sunami, E; Yasuda, K | 1 |
| Abe, M; Kiniwa, M; Matsuo, K; Nakagawa, F; Noguchi, S; Nukatsuka, M; Saito, H; Shibata, J; Uchida, J | 1 |
| Boku, N; Endo, T; Ikejiri, K; Kameoka, S; Kinugasa, Y; Kotake, K; Matsubara, Y; Mochizuki, H; Mochizuki, I; Nakamoto, Y; Shinozaki, H; Sugihara, K; Takagane, A; Takahashi, K; Takahashi, Y; Takii, Y; Takiuchi, H; Tomita, N; Watanabe, M; Watanabe, T | 1 |
| Chamorey, E; Dahan, L; Evesque, L; Follana, P; Francois, E; Mari, V; Michel, C; Perrier, H; Seitz, JF; Smith, D | 1 |
| Hwang, SH; Kim, SG | 1 |
| Ando, K; Kusumoto, T; Maeda, K; Maehara, Y; Munemoto, Y; Murata, A; Nakanishi, R; Nakashima, Y; Oki, E; Saeki, H; Shimokawa, M; Takahashi, T | 1 |
44 review(s) available for tegafur and uftoral
| Article | Year |
|---|---|
[Clinical use of platinum compounds and fluorinated pyrimidines for lung cancer].
Topics: Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Drug Combinations; Fluorouracil; Humans; Lung Neoplasms; Tegafur; Uracil | 1996 |
The role of chemotherapy in the treatment of head and neck cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Male; Maxillary Sinus Neoplasms; Peplomycin; Survival Rate; Tegafur; Uracil | 1997 |
Modulation of 5-FU and its related compounds.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fluorouracil; Humans; Neoplasms; Pyridines; Tegafur; Uracil | 1997 |
[Fundamental studies on the surgical adjuvant chemotherapy to support the clinical efficacies].
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma, Experimental; Mice; Mice, Nude; Rats; Rats, Inbred SHR; Semustine; Skin Neoplasms; Tegafur; Uracil | 1997 |
[Benefits of adjuvant chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Mitomycin; Randomized Controlled Trials as Topic; Tamoxifen; Tegafur; Uracil | 1997 |
[Adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vindesine | 1997 |
Experience with UFT in Japan.
Topics: Chemotherapy, Adjuvant; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Combinations; Humans; Japan; Neoplasms; Tegafur; Treatment Outcome; Uracil | 1997 |
Current and future directions in adjuvant combined-modality therapy of rectal cancer.
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Fluorouracil; Forecasting; Humans; Leucovorin; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Rectal Neoplasms; Tegafur; Uracil | 1997 |
Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Drug Combinations; Forecasting; Head and Neck Neoplasms; Humans; Neoplasm Staging; Tegafur; Uracil | 1997 |
UFT in gastric cancer: current status and future developments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials as Topic; Drug Combinations; Forecasting; Humans; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 1997 |
UFT: biochemical modulation for 5-fluorouracil (5-FU).
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Drug Combinations; Fluorouracil; Humans; Lung Neoplasms; Neoplasms; Tegafur; Uracil | 1997 |
Uracil-tegafur in gastric carcinoma: a comprehensive review.
Topics: Antineoplastic Agents; Drug Combinations; Humans; Stomach Neoplasms; Tegafur; Uracil | 1998 |
UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Lung Neoplasms; Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 1998 |
Oral fluoropyrimidines in the treatment of colorectal cancer.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Oxidoreductases; Pyridines; Tegafur; Uracil | 1998 |
[Gastrointestinal cancer and oral anticancer agents].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Camptothecin; Drug Combinations; Floxuridine; Fluorouracil; Gastrointestinal Neoplasms; Humans; Irinotecan; Organoplatinum Compounds; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil | 1999 |
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Schedule; Drug Combinations; Estramustine; Etoposide; Female; Flutamide; Humans; Kidney Neoplasms; Male; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1999 |
New drugs in therapy of colorectal cancer: preclinical studies.
Topics: Animals; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fluorouracil; Folic Acid Antagonists; Humans; Oxidoreductases; Prodrugs; Quinazolines; Tegafur; Thiophenes; Thymidine Phosphorylase; Thymidylate Synthase; Uracil | 1999 |
Oral fluoropoyrimidines.
Topics: Animals; Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Folic Acid Antagonists; Humans; Leucovorin; Oxidoreductases; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil | 1999 |
Oxaliplatin: a new therapeutic option in colorectal cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Drug Synergism; Fluorouracil; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Quinazolines; Tegafur; Thiophenes; Uracil | 1999 |
The role of tegafur/uracil in pulmonary malignancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Drug Combinations; Drug Synergism; Humans; Lung Neoplasms; Tegafur; Uracil | 1999 |
Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colorectal Neoplasms; Drug Combinations; Fluorouracil; Humans; Leucovorin; Tegafur; Uracil | 1999 |
Recent developments in oral chemotherapy options for gastric carcinoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Drug Combinations; Etoposide; Humans; Stomach Neoplasms; Tegafur; Uracil | 1999 |
The oral fluorinated pyrimidines.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Biological Availability; Biotransformation; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Enzyme Inhibitors; Fluorouracil; Humans; Neoplasms; Oxidoreductases; Prodrugs; Tegafur; Uracil | 2001 |
Answering patients' needs: oral alternatives to intravenous therapy.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Infusions, Intravenous; Patient Satisfaction; Quality of Life; Tegafur; Uracil | 2001 |
The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Combinations; Humans; Leucovorin; Lung Neoplasms; Tegafur; Treatment Outcome; Uracil | 2001 |
Nonsurgical treatment of hepatocellular carcinoma.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Capecitabine; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cryosurgery; Deoxycytidine; Drug Combinations; Ethanol; Fluorouracil; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Injections, Intralesional; Interferons; Liver Cirrhosis; Liver Neoplasms; Octreotide; Radiopharmaceuticals; Radiotherapy Dosage; Tamoxifen; Tegafur; Uracil | 2001 |
[Comparative clinical studies for head and neck cancer in Japan].
Topics: Antineoplastic Agents; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Drug Combinations; Head and Neck Neoplasms; Humans; Japan; Tegafur; Uracil | 2002 |
[Chemotherapy of gastric cancer--a review of clinical trials in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Combinations; Floxuridine; Humans; Japan; Methotrexate; Mitomycin; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 2002 |
[Phase III study of gynecologic cancer in Japan].
Topics: Adjuvants, Immunologic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Combinations; Female; Genital Neoplasms, Female; Humans; Japan; Multicenter Studies as Topic; Ovarian Neoplasms; Sizofiran; Survival Analysis; Tegafur; Uracil; Uterine Neoplasms | 2002 |
[Hormonal chemotherapy for hormone-refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drug Combinations; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |
Practical considerations in the use of oral fluoropyrimidines.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Oxonic Acid; Prodrugs; Pyridines; Tegafur; Uracil | 2003 |
[Chemotherapy for colorectal carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Tegafur; Uracil | 2003 |
Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Life Tables; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Neovascularization, Pathologic; Pneumonectomy; Postoperative Period; Prodrugs; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil; Vascular Endothelial Growth Factor A | 2004 |
[Second-line chemotherapy for advanced colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Quality of Life; Survival Rate; Tegafur; Uracil | 2005 |
Commentary on Wang et al., "Pre-operative chemotherapy with oral tegafur-uracil and leucovorin for rectal cancer" (J Surg Oncol 89: 256-263).
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Disease-Free Survival; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Preoperative Care; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
[Postoperative adjuvant chemotherapy for non-small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Mitomycin; Paclitaxel; Pneumonectomy; Postoperative Care; Randomized Controlled Trials as Topic; Tegafur; Uracil; Vinblastine; Vindesine; Vinorelbine | 2005 |
[Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Combinations; Evidence-Based Medicine; Humans; Lung Neoplasms; Meta-Analysis as Topic; Neoplasm Staging; Pneumonectomy; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2006 |
[Adjuvant chemotherapy for colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Combinations; Evidence-Based Medicine; Fluorouracil; Guidelines as Topic; Humans; Leucovorin; Lymph Node Excision; Neoplasm Staging; Survival Rate; Tegafur; Uracil | 2006 |
[Adjuvant treatment of colorectal cancer].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; Fluorouracil; Humans; Irinotecan; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Tegafur; Uracil | 2006 |
[Adjuvant chemotherapy for non-small cell lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Humans; Lung Neoplasms; Meta-Analysis as Topic; Pneumonectomy; Randomized Controlled Trials as Topic; Survival Rate; Tegafur; Uracil; Vinblastine; Vinorelbine | 2006 |
[Adjuvant chemotherapy for colorectal cancer in Japan-current state and problem areas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Europe; Evidence-Based Medicine; Fluorouracil; Humans; Irinotecan; Japan; Leucovorin; Neoplasm Staging; Oxonic Acid; Practice Guidelines as Topic; Rectal Neoplasms; Tegafur; United States; Uracil | 2007 |
On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclophosphamide; Disease Models, Animal; Drug Combinations; Humans; Mammary Neoplasms, Experimental; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Tegafur; Transplantation, Heterologous; Uracil | 2007 |
The multidisciplinary management of gastrointestinal cancer. The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cell Death; Cell Survival; Colorectal Neoplasms; Deoxycytidine; Drug Combinations; ErbB Receptors; Fluorouracil; Humans; Leucovorin; Neoplasm Metastasis; Tegafur; Treatment Outcome; Uracil; Vascular Endothelial Growth Factor A | 2007 |
UFT and S-1 for treatment of primary lung cancer.
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Drug Resistance, Neoplasm; Enzyme Inhibitors; Evidence-Based Medicine; Humans; Lung Neoplasms; Oxonic Acid; Radiotherapy, Adjuvant; Tegafur; Time Factors; Treatment Outcome; Uracil | 2010 |
66 trial(s) available for tegafur and uftoral
| Article | Year |
|---|---|
[A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Combinations; Female; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Picibanil; Prospective Studies; Survival Rate; Tegafur; Uracil; Vindesine | 1996 |
[Neoadjuvant therapy followed by administration of UFT for breast cancer patients].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Humans; Middle Aged; Remission Induction; Tegafur; Uracil | 1996 |
Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer.
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Leucovorin; Male; Neoplasm Staging; Prospective Studies; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 1996 |
[Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Prognosis; Survival Rate; Tegafur; Uracil | 1996 |
[Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 1996 |
A comparative, randomized trial of UFT and 5-fluorouracil in combination with cyclophosphamide and doxorubicin in the treatment of advanced breast cancer patients at The Philippines General Hospital.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Tegafur; Uracil | 1997 |
Clinical application of biochemical modulation in cancer chemotherapy: biochemical modulation for 5-FU.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Fluorouracil; Humans; Japan; Tegafur; Uracil | 1997 |
Phase II study of UFT plus leucovorin in colorectal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Neoplasm Metastasis; Survival Analysis; Tegafur; Uracil | 1997 |
UFT modulated with leucovorin in advanced colorectal cancer: Oncopaz experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Tegafur; Uracil | 1997 |
Experience of Oncopaz Cooperative Group with oral fluoropyrimidines in tumors of the stomach, lung, head and neck, and breast.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Head and Neck Neoplasms; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1997 |
[Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Tegafur; Uracil | 1997 |
Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 14-day schedule.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 1997 |
[Study of preoperative combination therapy with UFT + CDDP in patients with gastric and colorectal cancer--concomitant effects based on the thymidylate synthase inhibitory rat].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intravenous; Lymphatic Metastasis; Middle Aged; Rats; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 1997 |
Postsurgical sequential methotrexate, fluorouracil, and leucovorin for advanced colorectal carcinoma: a preliminary study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Mitomycin; Postoperative Period; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 1997 |
Scientific basis for the combination of tegafur with uracil.
Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Intestinal Absorption; Male; Middle Aged; Mitomycin; Postoperative Care; Stomach Neoplasms; Survival Analysis; Tegafur; Uracil | 1997 |
Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 1997 |
Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Drug Combinations; Fluorouracil; Humans; Leucovorin; Neoplasms; Tegafur; Tetrahydrofolates; Uracil | 1997 |
Postoperative adjuvant chemotherapy with mitomycin C and UFT for rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Female; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prospective Studies; Rectal Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |
5-FU or UFT combined with leucovorin for previously untreated metastatic colorectal Ca.
Topics: Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Tegafur; Uracil | 1997 |
UFT plus leucovorin vs 5-FU plus leucovorin for metastatic colorectal cancer.
Topics: Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Drug Therapy, Combination; Fluorouracil; Humans; Leucovorin; Middle Aged; Tegafur; Uracil | 1997 |
A preliminary report of a phase II trial. UFT plus oral folinic acid as therapy for metastatic colorectal cancer in older patients. Spanish Group for the Treatment of Gastrointestinal Tumors (TTd Group).
Topics: Aged; Aged, 80 and over; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Leukopenia; Male; Nausea; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 1997 |
Preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer.
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Feasibility Studies; Fluorouracil; Humans; Leucovorin; Radiotherapy Dosage; Rectal Neoplasms; Tegafur; Uracil | 1997 |
UFT in combination as adjuvant therapy for breast cancer. Grupo Oncologico de Sevilla Seville, Spain.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Combinations; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Postmenopause; Prednimustine; Premenopause; Spain; Survival Analysis; Tamoxifen; Tegafur; Uracil | 1997 |
Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.
Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Drug Combinations; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |
Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Humans; Japan; Lung Neoplasms; Multivariate Analysis; Postoperative Care; Prognosis; Survival Rate; Tegafur; Uracil | 1997 |
UFT plus cisplatin in advanced non-small-cell lung cancer: interim analysis of 67 patients.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Combinations; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Tegafur; Thrombocytopenia; Uracil; Vomiting | 1997 |
UFT plus cisplatin for advanced gastric cancer.
Topics: Adolescent; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Drug Combinations; Humans; Leukopenia; Middle Aged; Mitomycins; Nausea; Pilot Projects; Stomach Neoplasms; Tegafur; Uracil | 1997 |
The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
Topics: Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Drug Combinations; Etoposide; Female; Forecasting; Humans; Leucovorin; Male; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1997 |
A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
Topics: Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Diarrhea; Drug Combinations; Female; Follow-Up Studies; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Treatment Outcome; Uracil | 1997 |
UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas.
Topics: Adenocarcinoma; Adult; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cholangiocarcinoma; Drug Combinations; Humans; Leucovorin; Liver Neoplasms; Pancreatic Neoplasms; Quality of Life; Tegafur; Treatment Outcome; Uracil | 1997 |
Pilot study of UFT combined with 5 consecutive days cisplatin in non-small cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Feasibility Studies; Female; Humans; Lung Neoplasms; Male; Middle Aged; Patient Compliance; Pilot Projects; Tegafur; Uracil | 1997 |
Phase III randomized comparison of postoperative adjuvant chemotherapy with 2-year oral UFT (uracil/tegafur) versus six-cycle CMF (cyclophosphamide/methotrexate/5-fluorouracil) in high-risk node-negative breast cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Tegafur; Uracil | 1998 |
[Phase I study of orally administered UFT plus l-leucovorin].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Gastrointestinal Neoplasms; Humans; Leucovorin; Male; Middle Aged; Nausea; Stomach Neoplasms; Tegafur; Uracil; Vomiting | 1998 |
[Adjuvant chemotherapy with UFT or UFT with OK-432 to patients with gastric and colorectal cancer. Kanto Adjuvant Study Group].
Topics: Adjuvants, Immunologic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Combinations; Humans; Middle Aged; Picibanil; Rectal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 1998 |
A crossover study of oral administration of UFT in chronic liver disease: comparison of continuous and intermittent schedules.
Topics: Administration, Oral; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chronic Disease; Cross-Over Studies; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Gastritis; Gastrointestinal Hemorrhage; Humans; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Nausea; Tegafur; Treatment Outcome; Uracil | 1998 |
[Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Diethylstilbestrol; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Prostatic Neoplasms; Tegafur; Uracil; Urinary Bladder Neoplasms | 1998 |
Potential of the histoculture drug-response assay to contribute to cancer patient survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Multivariate Analysis; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Tumor Stem Cell Assay; Uracil | 1995 |
Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Cohort Studies; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Fatigue; Female; Fluorouracil; Humans; Male; Middle Aged; Nausea; Prodrugs; Tegafur; Uracil; Vomiting | 1996 |
Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological Availability; Colorectal Neoplasms; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Tegafur; Uracil | 1999 |
A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Humans; Leucovorin; Neoplasms; Organoplatinum Compounds; Tegafur; Treatment Outcome; Uracil; Vomiting | 1999 |
Efficacy of UFT plus oral leucovorin in advanced colorectal cancer: a multicenter study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Prognosis; Severity of Illness Index; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2000 |
Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Biological Availability; Colorectal Neoplasms; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Combinations; Fasting; Female; Fluorouracil; Food; Humans; Leucovorin; Male; Middle Aged; Tegafur; Tetrahydrofolates; Time Factors; Uracil | 2001 |
Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multicenter prospective randomized trial.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease-Free Survival; Drug Combinations; Female; Humans; Male; Middle Aged; Postoperative Period; Prospective Studies; Recurrence; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2002 |
Oxaliplatin and UFT combination chemotherapy in patients with metastatic colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Survival Analysis; Tegafur; Uracil | 2002 |
[Hormonal chemotherapy for hormone-refractory prostate cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Drug Combinations; Estramustine; Humans; Male; Middle Aged; Prostatic Neoplasms; Tegafur; Uracil | 2002 |
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Gene Expression Regulation, Neoplastic; Humans; Leucovorin; Male; Middle Aged; Orotate Phosphoribosyltransferase; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2003 |
[Phase I study of gemcitabine (GEM) and UFT combination chemotherapy for unresectable/recurrent pancreatic cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Female; Gemcitabine; Humans; Leukopenia; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pancreatic Neoplasms; Tegafur; Uracil | 2004 |
Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-flu
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Injections, Subcutaneous; Male; Middle Aged; Mitomycin; Neoplasm Staging; Picibanil; Pyrimidines; Radiotherapy, Adjuvant; Rectal Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2004 |
[Clinical usefulness of UFT and cyclophosphamide as salvage chemotherapy for patients with metastatic breast cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Routes; Drug Combinations; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Skin Neoplasms; Tegafur; Thrombocytopenia; Uracil | 2004 |
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Combinations; Epirubicin; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Nausea; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
A phase II trial of UFT and leucovorin in women 65 years and older with advanced breast cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Drug Combinations; Female; Humans; Leucovorin; Tegafur; Uracil | 2005 |
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome; Uracil | 2005 |
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Esophageal Neoplasms; Female; Humans; Leucovorin; Male; Middle Aged; Radiation-Sensitizing Agents; Tegafur; Uracil | 2005 |
[Pharmacokinetic modulating chemotherapy highly effective for colorectal carcinoma metastases to multiple organs].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chronotherapy; Colorectal Neoplasms; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Tegafur; Uracil | 2005 |
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leukopenia; Male; Middle Aged; Nausea; Quality of Life; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory | 2005 |
[Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
[Clinical evaluation of chemotherapy with irinotecan (CPT-11), l-leucovorin (l-LV), 5-fluorouracil (5-FU), and UFT for metastatic or recurrent colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Nausea; Rectal Neoplasms; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory | 2005 |
[Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Tegafur; Uracil | 2006 |
An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Colorectal Neoplasms; Combined Modality Therapy; Disease-Free Survival; Drug Combinations; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Period; Survival Rate; Tegafur; Uracil | 2007 |
Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Drug Combinations; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rectal Neoplasms; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2008 |
A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2008 |
Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
Topics: Administration, Oral; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Etoposide; Female; Humans; Kaplan-Meier Estimate; Leucovorin; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Tegafur; Uracil | 2009 |
PSK may suppress CD57(+) T cells to improve survival of advanced gastric cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CD57 Antigens; Chemotherapy, Adjuvant; Chi-Square Distribution; Drug Combinations; Female; Fungal Proteins; Gastrectomy; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Polysaccharides; Stomach Neoplasms; T-Lymphocyte Subsets; Tegafur; Time Factors; Treatment Outcome; Uracil | 2010 |
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Disease-Free Survival; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Oxonic Acid; Tegafur; Uracil | 2012 |
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II study.
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Colorectal Neoplasms; Drug Combinations; Drug Monitoring; Female; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Grading; Salvage Therapy; Survival Analysis; Tegafur; Tumor Burden; Uracil | 2012 |
Effect of lateral lymph node dissection for mid and low rectal cancer: An ad-hoc analysis of the ACTS-RC (JFMC35-C1) randomized clinical trial.
Topics: Abdomen; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonoscopy; Disease-Free Survival; Drug Combinations; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Rectal Neoplasms; Retrospective Studies; Tegafur; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uracil; Young Adult | 2019 |
162 other study(ies) available for tegafur and uftoral
| Article | Year |
|---|---|
Severe chronic active hepatitis induced by UFTR containing tegafur and uracil.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Colonic Neoplasms; Drug Combinations; Female; Humans; Tegafur; Uracil | 1995 |
Prolongation of survival period and improvement of cancer cachexia by long-term administration of UFT.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Dogs; Drug Administration Schedule; Drug Combinations; Interleukin-6; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Tegafur; Uracil | 1996 |
[Evaluation of subrenal capsule assay (SRC) for clinical cancers].
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Colorectal Neoplasms; Drug Combinations; Esophageal Neoplasms; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Stomach Neoplasms; Subrenal Capsule Assay; Tegafur; Uracil | 1996 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1996 |
[Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Colonic Neoplasms; Dinoprostone; Doxorubicin; Drug Combinations; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Mitomycin; Survival Analysis; Tegafur; Tumor Cells, Cultured; Uracil | 1996 |
[A case of hepatocellular carcinoma responding to oral administration of UFT].
Topics: Administration, Oral; Aged; alpha-Fetoproteins; Biomarkers; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Protein Precursors; Prothrombin; Tegafur; Uracil | 1996 |
The modulating effect of interferon alpha-2a on the antitumor activity of UFT against a human gastric carcinoma xenograft, SC-1-NU, in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Combined Modality Therapy; DNA Replication; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Rats; Recombinant Proteins; RNA, Neoplasm; Stomach; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Transplantation, Heterologous; Uracil | 1996 |
[Acute lymphoblastic leukemia with marked morphologic abnormalities after chemotherapy for gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Humans; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[A case report of concomitant UFT-E and CDDP against lung epidermoid carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Combinations; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer remarkably responding to preoperative UFT-E therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Humans; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[Successful UFT-E granule and 5-FUCDDP combination therapy for an unresectable advanced gastric cancer complicated with liver metastasis].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinations; Gastrectomy; Humans; Liver Neoplasms; Male; Parenteral Nutrition, Home; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[An elderly patient with gastric cancer surviving long after chemotherapy using UFT alone].
Topics: Activities of Daily Living; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Male; Stomach Neoplasms; Survivors; Tegafur; Uracil | 1996 |
[Inhibition of prostate cancer growth in nude mice by hormone and chemotherapy].
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Drug Combinations; Drug Synergism; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Tegafur; Uracil | 1996 |
[A case of advanced gastric cancer with multiple liver metastasis successfully treated with combination chemotherapy using UFT, CDDP and etoposide].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Injections, Intravenous; Lentinan; Leukopenia; Liver Neoplasms; Male; Nausea; Stomach Neoplasms; Tegafur; Thrombocytopenia; Uracil | 1996 |
A case of advanced gastric cancer complicated by severe toxicity induced by a combination of tegafur, uracil and mitomycin C, and associated with abnormal pharmacokinetics.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bone Marrow Diseases; Diarrhea; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Mitomycin; Oxidoreductases; Stomach Neoplasms; Tegafur; Uracil | 1996 |
[Usefulness of contrast-enhanced CT of the peritoneum to evaluate efficacy of neoadjuvant chemotherapy for peritoneal dissemination in an advanced gastric cancer case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Humans; Male; Peritoneal Neoplasms; Peritoneum; Radiographic Image Enhancement; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 1996 |
Biochemical modulation: its pharmacological basis and clinical applications. Proceedings of a meeting. Singapore, October 19, 1995.
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Fluorouracil; Humans; Prodrugs; Tegafur; Uracil | 1997 |
Mechanism-based improvement in the therapeutic selectivity of 5-FU prodrug alone and under conditions of metabolic modulation.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Drug Synergism; Fluorouracil; Leucovorin; Prodrugs; Rats; Tegafur; Uracil | 1997 |
[Antimetastatic effects of UFT on murine liver metastasis model using L5178YHM lymphoma].
Topics: Animals; Body Weight; Drug Combinations; Floxuridine; Leukemia L5178; Liver Neoplasms; Male; Mice; Tegafur; Uracil | 1996 |
[Immunotoxic effects of a new antineoplastic agent S-1 in mice--comparison with S-1, UFT and 5-FU].
Topics: Animals; Antibody Formation; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Fluorouracil; Immune System; Immune Tolerance; Immunologic Tests; Mice; Mice, Inbred BALB C; Organ Size; Oxonic Acid; Pyridines; Spleen; Tegafur; Thymus Gland; Uracil | 1996 |
[Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Embolization, Therapeutic; Humans; Interferon-alpha; Kidney Neoplasms; Male; Neoplastic Cells, Circulating; Renal Artery; Tegafur; Uracil | 1997 |
[A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 1997 |
Inhibitory effects of fluorinated pyrimidines, 5'-DFUR, UFT and T-506, in a model of hepatic metastasis of mouse colon 26 adenocarcinoma-assessment of inhibitory activity and adverse reactions at the maximum tolerated dose.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Combinations; Female; Floxuridine; Fluorodeoxyuridylate; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Tegafur; Uracil | 1997 |
[A case of far-advanced gastric cancer treated with neoadjuvant combination chemotherapy of UFT, low-dose CDDP and leucovorin, followed by subtotal gastrectomy with curative intent].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Leucovorin; Male; Neoplasm Invasiveness; Portal Vein; Stomach Neoplasms; Tegafur; Uracil | 1997 |
UFT: East meets West in drug development.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Drug Therapy, Combination; Humans; Japan; Leucovorin; Neoplasms; Tegafur; United States; Uracil | 1997 |
Rationale for phase I study of UFT plus leucovorin and oral JM-216.
Topics: Administration, Oral; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Combinations; Drug Therapy, Combination; Humans; Leucovorin; Organoplatinum Compounds; Tegafur; Uracil | 1997 |
Future directions in the adjuvant treatment of colon cancer.
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Drug Therapy, Combination; Fluorouracil; Forecasting; Humans; Leucovorin; Tegafur; Uracil | 1997 |
Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.
Topics: Adult; Anemia; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Diarrhea; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Neutropenia; Survival Rate; Tegafur; Uracil | 1997 |
A pharmacoeconomic comparison of UFT and 5-FU chemotherapy for colorectal cancer in South America.
Topics: Argentina; Brazil; Chemotherapy, Adjuvant; Colorectal Neoplasms; Costs and Cost Analysis; Drug Combinations; Drug Costs; Fluorouracil; Humans; Monte Carlo Method; South America; Tegafur; Uracil | 1997 |
The University of Texas M.D. Anderson Cancer Center Investigators' Workshop and Consensus Conference on UFT. January 17-18, 1997.
Topics: Drug Combinations; Humans; Tegafur; Uracil | 1997 |
[Prognostic effect of PyNPase (pyrimidine nucleoside phosphorylase) activity in breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Combinations; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Pentosyltransferases; Prognosis; Pyrimidine Phosphorylases; S Phase; Survival Rate; Tamoxifen; Tegafur; Uracil | 1998 |
A case of malignant peritoneal mesothelioma showed complete remission with chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Cisplatin; Combined Modality Therapy; Drug Combinations; Etoposide; Female; Humans; Mesothelioma; Neoplasms, Unknown Primary; Peritoneal Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
[Preoperative chemotherapy for advanced colorectal carcinomas--comparison of histological effect between UFT + leucovorin tablet and UFT alone].
Topics: Administration, Oral; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms; Tablets; Tegafur; Uracil | 1998 |
[A case of gastric cancer with peritonitis carcinomatosa and malignant biliary stenosis treated by intraperitoneal CDDP and MMC with UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Diseases; Cisplatin; Drainage; Drug Combinations; Humans; Injections, Intraperitoneal; Male; Middle Aged; Mitomycin; Peritonitis; Stomach Neoplasms; Tegafur; Uracil | 1998 |
Combination therapy of active hexose correlated compound plus UFT significantly reduces the metastasis of rat mammary adenocarcinoma.
Topics: Adenocarcinoma; Animals; Basidiomycota; Cell Survival; Drug Combinations; Female; Killer Cells, Natural; Macrophages, Peritoneal; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Nitric Oxide; Polysaccharides; Rats; Rats, Inbred SHR; Spleen; T-Lymphocytes; Tegafur; Uracil | 1998 |
[A case of hepatocellular carcinoma with reduction of primary tumor and disappearance of multiple lung metastasis].
Topics: Administration, Oral; alpha-Fetoproteins; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Tegafur; Uracil | 1998 |
[Complete disappearance of metastatic pulmonary tumors in a case of hepatocellular carcinoma treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Female; Humans; Liver Neoplasms; Lung Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
[A case of giant hepatocellular carcinoma effectively treated with UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Male; Remission Induction; Tegafur; Uracil | 1998 |
[Complete remission of liver metastasis from rectal cancer following continuous oral administration of tegafur-uracil after intrahepatic arterial single injection of CDDP and 5-FU].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Fluorouracil; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 1998 |
Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Drug Combinations; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Postoperative Care; Prognosis; Retrospective Studies; Survival Rate; Tegafur; Uracil | 1998 |
Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cricetinae; Drug Combinations; Lymphatic Metastasis; Male; Mouth Neoplasms; Neoplasm Transplantation; Tegafur; Uracil | 1998 |
[A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Administration Schedule; Drug Combinations; Humans; Male; Tegafur; Uracil; Urinary Bladder Neoplasms | 1998 |
[A case of multiple early gastric cancer showing complete response to UFT-E after endoscopic mucosal resection].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Endoscopy; Gastric Mucosa; Gastroscopy; Humans; Male; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 1999 |
[A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Duodenum; Epirubicin; Female; Fluorouracil; Gallbladder Neoplasms; Hepatectomy; Humans; Infusions, Intra-Arterial; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Pancreatectomy; Tegafur; Uracil | 1999 |
[A case of laryngeal cancer treated for over 2 years with UFT and CBDCA alone].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Drug Combinations; Humans; Infusions, Intravenous; Laryngeal Neoplasms; Male; Tegafur; Uracil | 1999 |
[A case of carcinoma of lower lip showing excellent response to chemotherapy with UFT].
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Combinations; Female; Humans; Lip; Lip Neoplasms; Tegafur; Uracil | 1999 |
[A case in which palatal squamous cell carcinoma responded to UFT therapy].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Combinations; Female; Humans; Palatal Neoplasms; Remission Induction; Tegafur; Uracil | 1999 |
Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotaxis; Cisplatin; Clone Cells; Drug Combinations; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; RNA, Messenger; RNA, Neoplasm; Tegafur; Tissue Inhibitor of Metalloproteinase-1; Tumor Cells, Cultured; Uracil | 1999 |
[A case of esophageal cancer with excellent response to oral UFT treatment].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Esophagoscopy; Humans; Male; Tegafur; Uracil | 1999 |
Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Colorectal Neoplasms; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Female; HT29 Cells; Humans; Leucovorin; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin; Tegafur; Transplantation, Heterologous; Uracil | 2000 |
[A case of gastric cancer with liver metastases successfully treated with combination therapy of systemic and hepatic arterial infusion chemotherapy].
Topics: Administration, Oral; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Combinations; Fluorouracil; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Mitomycin; Stomach Neoplasms; Tegafur; Uracil | 2001 |
[Complete response of a massive hepatocellular carcinoma with lung metastasis to UFT (DPD inhibitory fluoroprymidines: DIF)].
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Neoplasms; Lung Neoplasms; Male; Tegafur; Uracil | 2001 |
[Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Combinations; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Transplantation; Rats; Rats, Nude; Tegafur; Transplantation, Heterologous; Uracil | 2001 |
A pharmacological study of the weekday-on/weekend-off oral UFT schedule in colorectal cancer patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Tegafur; Uracil | 2001 |
[A case of advanced gastric cancer with multiple liver metastases in an elderly patient that responded dramatically to UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Liver Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 2001 |
[Efficacy of intraperitoneal chemotherapy for peritoneal recurrence of gastric carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Gastrectomy; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Mitomycin; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur; Uracil | 2001 |
Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Drug Combinations; Floxuridine; Fluorouracil; Intestinal Mucosa; Leukemia L1210; Male; Mice; Tegafur; Uracil | 2001 |
[A case of breast cancer with multiple metastases effectively treated with long-term administration of docetaxel, aclarubicin and UFT].
Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Liver Neoplasms; Lung Neoplasms; Middle Aged; Paclitaxel; Taxoids; Tegafur; Uracil | 2001 |
[A case of squamous cell carcinoma of the oral floor showing a complete response to oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Mouth Neoplasms; Remission Induction; Tegafur; Uracil | 2001 |
[A case of spindle cell type hepatocellular carcinoma responding to hepatic intra-arterial infusion chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Tegafur; Uracil | 2002 |
[Gamma-hydroxybutyric acid, a metabolite of UFT, shows anti-angiogenic activities and antitumor effect].
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Drug Combinations; Endothelial Growth Factors; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Lymphokines; Mice; Mice, Nude; Neoplasm Transplantation; Sodium Oxybate; Tegafur; Tumor Cells, Cultured; Uracil; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
[Antimetastatic and antitumor effects of fluoropyrimidines alone and combined with taxanes in a murine model of breast cancer metastatic to the lung].
Topics: Aminoacridines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Disease Models, Animal; Drug Combinations; Female; Floxuridine; Humans; Lung Neoplasms; Mice; Mice, Inbred ICR; Mice, SCID; Neoplasm Transplantation; Taxoids; Tegafur; Uracil | 2002 |
[Primary signet ring cell carcinoma of the urinary bladder: a case report].
Topics: Aged; Antineoplastic Agents; Carcinoma, Signet Ring Cell; Drug Combinations; Humans; Male; Tegafur; Uracil; Urinary Bladder Neoplasms | 2001 |
[Dormant chemotherapy by low-dose FP and low-dose UFT-E in recurrent gastric cancer with long-term survival--a case report].
Topics: Adenocarcinoma, Papillary; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms; Survivors; Tegafur; Uracil | 2002 |
gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Chemotaxis; Colonic Neoplasms; DNA Replication; Drug Combinations; Endothelial Growth Factors; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Floxuridine; Fluorouracil; Humans; Intercellular Signaling Peptides and Proteins; Kidney Neoplasms; Lung Neoplasms; Lymphokines; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Neoplasm Proteins; Neovascularization, Pathologic; Prodrugs; Prostheses and Implants; Recombinant Proteins; Sodium Oxybate; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured; Uracil; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays | 2001 |
[A case of complete response (CR) persisting for 2 years and 10 months from UFT-E in a patient with liver metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Humans; Leucovorin; Liver Neoplasms; Lymph Node Excision; Male; Methotrexate; Middle Aged; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2002 |
[A case of liver metastasis of rectal cancer demonstrating complete response to 5-FU + Leucovorin + UFT].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2002 |
[CPT-11 hepatic arterial injection plus oral UFT administration for liver metastasis of rectal cancer--report of two cases].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Drug Combinations; Hepatic Artery; Humans; Injections, Intra-Arterial; Irinotecan; Liver Neoplasms; Male; Middle Aged; Rectal Neoplasms; Tegafur; Uracil | 2002 |
Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Oxidoreductases; Postoperative Care; Prognosis; Retrospective Studies; Survival Analysis; Tegafur; Treatment Outcome; Uracil | 2002 |
[A case of preoperative concurrent chemoradiotherapy and curative resection for locally advanced non-small-cell lung cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Combinations; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Preoperative Care; Tegafur; Uracil | 2002 |
[A trial of continuous and biweekly low-dose cisplatin and 5-FU with UFT chemotherapy for esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 2002 |
[A case of colon metastasis to the lung treated successfully with combined chemotherapy of CPT-11 and 5'-DFUR].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Drug Combinations; Floxuridine; Fluorouracil; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Rectal Neoplasms; Tegafur; Uracil | 2002 |
Oral uracil/ftorafur (UFT) plus leucovorin as first-line chemotherapy and salvage therapy with weekly high-dose 5-fluorouracil/leucovorin for the treatment of metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms; Salvage Therapy; Tegafur; Uracil | 2002 |
Prognostic significance of p53 status in non-small cell lung cancer in correlation with postoperative adjuvant therapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Combinations; Female; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Postoperative Care; Prognosis; Survival Analysis; Tegafur; Treatment Outcome; Tumor Suppressor Protein p53; Uracil | 2002 |
[A case of postoperative hepatic metastasis from gastric cancer responding to hepatic arterial infusion chemotherapy of paclitaxel].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Male; Paclitaxel; Stomach Neoplasms; Tegafur; Uracil | 2002 |
[Modified pharmacokinetic modulation chemotherapy (PMC) with medication of UFT and intraarterial infusion of 5-FU for advanced unresectable HCC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Survival Rate; Tegafur; Uracil | 2002 |
[A case of para-aortic lymph node recurrence of gallbladder cancer completely responding to single drug (UFT) chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Ducts, Extrahepatic; Cholecystectomy; Drug Administration Schedule; Drug Combinations; Gallbladder Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Tegafur; Uracil | 2003 |
[Neoadjuvant chemotherapy with nedaplatin and UFT for oral squamous cell carcinomas].
Topics: Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Nausea; Neoadjuvant Therapy; Organoplatinum Compounds; Preoperative Care; Tegafur; Uracil | 2003 |
[A case report of tongue squamous cell carcinoma showing a complete response to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combinations; Female; Humans; Oxonic Acid; Pyridines; Remission Induction; Tegafur; Tongue Neoplasms; Uracil | 2003 |
[Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Gemcitabine; Humans; Lung Neoplasms; Male; Pleural Effusion, Malignant; Tegafur; Uracil; Vinblastine; Vinorelbine | 2003 |
[A case of recurrent breast cancer with lung metastasis and overexpression of HER2 that responded to UFT and cyclophosphamide combination therapy after sequential treatments with epirubicin, taxanes, and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Combinations; Epirubicin; Female; Humans; Lung Neoplasms; Mastectomy, Segmental; Middle Aged; Receptor, ErbB-2; Taxoids; Tegafur; Trastuzumab; Uracil | 2003 |
[UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Radiotherapy Dosage; Survival Rate; Tegafur; Uracil | 2003 |
Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Drug Combinations; Female; Fluorouracil; Imidazoles; Luciferases; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Osteoclasts; Tegafur; Uracil; Zoledronic Acid | 2003 |
[A case of multiple lung metastases from colon cancer after sigmoidectomy treated effectively by chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Sigmoid Neoplasms; Tegafur; Uracil | 2003 |
Oral tegafur-uracil plus leucovorin in metastatic colorectal cancer: clinical insights. Proceedings of a roundtable expert meeting. October 2002, Nice, France.
Topics: Adenocarcinoma; Antineoplastic Agents; Colorectal Neoplasms; Drug Combinations; Humans; Leucovorin; Neoplasm Metastasis; Tegafur; Uracil | 2003 |
[Simultaneous detection of both non-Hodgkin's lymphoma cells and breast cancer cells in pleural effusion--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Combinations; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pleural Effusion; Prednisone; Tamoxifen; Tegafur; Uracil; Vincristine | 2003 |
[Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Middle Aged; Orotate Phosphoribosyltransferase; Proportional Hazards Models; RNA, Messenger; Tegafur; Thymidylate Synthase; Tumor Suppressor Protein p53; Uracil | 2003 |
[A case of liver and lung metastases of rectal cancer responding well to 5-FU hepato-arterial infusion (HAI) with combined use of oral UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lung Neoplasms; Male; Rectal Neoplasms; Tegafur; Uracil | 2003 |
[A case of liver metastases from gastric cancer successfully treated with induced hypertensive chemotherapy].
Topics: Aged; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Brain Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Hepatectomy; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Proteoglycans; Radiosurgery; Stomach Neoplasms; Tegafur; Uracil | 2003 |
[A case of hepatic metastasis and local recurrence from rectal cancer responding to hepatic arterial infusion and systemic chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Drug Combinations; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Rectal Neoplasms; Tegafur; Uracil | 2003 |
[Long-term survival after neck lymph node metastases from sigmoid colon cancer--a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Lymph Nodes; Lymphatic Metastasis; Neck; Sigmoid Neoplasms; Survivors; Tegafur; Uracil | 2003 |
[A case of advanced gastric cancer with multiple liver metastases responding completely to hepatic arterial infusion and systemic chemotherapies].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2003 |
[A case of liver metastatic recurrence of bile duct cancer completely responding to single drug, UFT, chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bile Duct Neoplasms; Common Bile Duct; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Male; Radiotherapy, High-Energy; Remission Induction; Tegafur; Uracil | 2004 |
[Clinical significance of TS and DPD activities in colorectal carcinoma as a predictive factor of UFT sensitivity].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Apoptosis; Chemotherapy, Adjuvant; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Staging; Tegafur; Thymidylate Synthase; Uracil | 2004 |
[A case of huge submandibular malignant tumor treated successfully with UFT chemotherapy].
Topics: Administration, Oral; Aged; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Submandibular Gland Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2004 |
[A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Lentinan; Middle Aged; Neoplasm Invasiveness; Peritoneal Neoplasms; Peritoneum; Stomach Neoplasms; Survivors; Tegafur; Uracil | 2004 |
Severe colitis after administration of UFT chemotherapy for temporal bone carcinoma.
Topics: Antineoplastic Agents; Colonic Diseases; Colonoscopy; Drug Combinations; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Skull Neoplasms; Tegafur; Temporal Bone; Uracil | 2004 |
[A case of gastric cancer with a synchronous hepatic metastasis responding to postoperative oral administration of UFT and intermittent intrahepatic arterial chemotherapy of 5-FU].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gastrectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Male; Neoplasms, Multiple Primary; Remission Induction; Stomach Neoplasms; Tegafur; Uracil | 2004 |
[A case of highly advanced ascending colon cancer with multiple bone and liver metastases and pleuritis carcinomatosa treated with pharmacokinetic modulating chemotherapy and low-dose CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Male; Middle Aged; Pleurisy; Quality of Life; Tegafur; Uracil | 2004 |
[Renal transplantation surgery is closely linked with treatment for bilateral synchronous renal cell carcinomas or renal tumors in solitary kidney].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Female; Humans; Interferon-alpha; Kidney; Kidney Neoplasms; Kidney Transplantation; Living Donors; Male; Middle Aged; Neoplasms, Multiple Primary; Nephrectomy; Postoperative Care; Tegafur; Transplantation, Autologous; Uracil | 2004 |
[Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Home Care Services, Hospital-Based; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Nausea; Postoperative Care; Tegafur; Uracil; Vomiting, Anticipatory | 2004 |
[Tumoral dihydropyrimidine dehydrogenase expression and efficacy of 5-fluorouracil plus leucovorin plus UFT therapy in patients with colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dihydrouracil Dehydrogenase (NADP); Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Tegafur; Uracil | 2004 |
[Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cholestasis; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Drug Eruptions; Female; Gemcitabine; Heart Failure; Humans; Jaundice, Obstructive; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Stents; Survivors; Tegafur; Uracil | 2004 |
Spontaneous regression of recurrent squamous cell carcinoma of the tongue.
Topics: Aged; Carcinoma, Squamous Cell; Drug Combinations; Humans; Male; Neoplasm Recurrence, Local; Neoplasm Regression, Spontaneous; Tegafur; Tongue Neoplasms; Uracil | 2004 |
[A case of liver metastases of breast cancer successfully treated by combination chemotherapy using hepatic arterial infusion of docetaxel and systemic administration of trastuzumab].
Topics: Administration, Oral; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Mastectomy, Segmental; Taxoids; Tegafur; Trastuzumab; Uracil | 2004 |
[A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gemcitabine; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Male; Pancreatic Neoplasms; Quality of Life; Tegafur; Uracil | 2004 |
[A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Combined Modality Therapy; Drug Combinations; Duodenal Neoplasms; Fluorouracil; Gallbladder Neoplasms; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Mitomycin; Palliative Care; Stents; Tegafur; Uracil | 2004 |
[Urachal carcinoma treated with neoadjuvant intra-arterial chemotherapy: a case report].
Topics: Adenocarcinoma, Papillary; Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intra-Arterial; Male; Tegafur; Urachus; Uracil | 2004 |
Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p16; Drug Combinations; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Postoperative Period; Rectal Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 2004 |
[A case of synchronous double cancer responding to UFT--dermoid cyst with secondary malignant transformation and uterine endometrial adenocarcinoma].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Carcinoma, Adenosquamous; Combined Modality Therapy; Dermoid Cyst; Drug Combinations; Endometrial Neoplasms; Female; Humans; Hysterotomy; Neoplasms, Multiple Primary; Ovarian Neoplasms; Ovariectomy; Quality of Life; Salpingostomy; Tegafur; Uracil | 2005 |
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Palliative Care; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
[A case of liver metastases from cecal cancer successfully treated with fluorouracil and folinic acid (UFT/LV)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cecal Neoplasms; Chemotherapy, Adjuvant; Colectomy; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Tegafur; Uracil | 2005 |
[Pharmacokinetic modulating chemotherapy for rectal carcinoma metastases to the liver and lung--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Rectal Neoplasms; Tegafur; Uracil | 2005 |
UFT inhibits lung metastases in spontaneous metastasis model of lung cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Drug Combinations; Humans; Hydroxybutyrates; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Tegafur; Uracil | 2005 |
[Modified pharmacokinetic modulating chemotherapy for progressive gastric cancer accompanied by peritoneal dissemination].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Uracil | 2005 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Disseminated Intravascular Coagulation; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Methotrexate; Middle Aged; Paclitaxel; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[A case with advanced carcinoma of the gallbladder responding to UFT monotherapy].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Drug Combinations; Female; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Quality of Life; Tegafur; Uracil | 2005 |
[A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by UFT, cyclophosphamide and medroxyprogesterone acetate].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Cyclophosphamide; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Taxoids; Tegafur; Uracil | 2005 |
[Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Hepatic Artery; Humans; Infusions, Intra-Arterial; Leucovorin; Liver Neoplasms; Male; Middle Aged; Tegafur; Uracil | 2005 |
[Case report--postoperative continuous intraarterial infusion of small doses of 5-FU successfully controlled residual tumor and liver metastasis of stage IV gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Drug Combinations; Floxuridine; Fluorouracil; Gastrectomy; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Mitomycin; Neoplasm Staging; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil | 2005 |
[A case of colon cancer with multiple liver, lung and bone metastases successfully treated with combined weekly high-dose 5-FU (WHF) chemotherapy with UFT and CPT-11].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Irinotecan; Liver Neoplasms; Lung Neoplasms; Middle Aged; Tegafur; Uracil | 2005 |
[A case of multiple lung metastases of sigmoid colon cancer responding well to oral UFT+leucovorin therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Lung Neoplasms; Middle Aged; Pneumonectomy; Quality of Life; Sigmoid Neoplasms; Tegafur; Uracil | 2005 |
[A case of rectal cancer treated by preoperative chemoradiation].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colostomy; Drug Administration Schedule; Drug Combinations; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Preoperative Care; Rectal Neoplasms; Rectum; Remission Induction; Tegafur; Uracil | 2005 |
[Usefulness in predicting parameters for the selection of responders who received immunochemotherapy with PSK in patients with colorectal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; CD4-Positive T-Lymphocytes; Colorectal Neoplasms; Drug Combinations; Female; Humans; Interleukin-10; Interleukin-6; Male; Middle Aged; Proteoglycans; Tegafur; Uracil | 2005 |
[Clinical study of ambulatory patient cancer chemotherapy for advanced colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Stomatitis; Survival Rate; Tegafur; Uracil | 2005 |
[A case of recurrent colon cancer responding completely to uracil/tegafur (UFT) plus oral leucovorin (LV) therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colectomy; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Lymph Node Excision; Neoplasm Recurrence, Local; Remission Induction; Tegafur; Uracil | 2005 |
[Thymidylate synthase and dihydropyrimidine dehydrogenase expression and histological effects of preoperative UFT in gastric cancer patients].
Topics: Aged; Antineoplastic Agents; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Stomach Neoplasms; Tegafur; Thymidylate Synthase; Uracil | 2006 |
[A case of unresectable non-small cell lung cancer with pleural dissemination successfully treated with DIF].
Topics: Adenocarcinoma, Papillary; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Humans; Lung Neoplasms; Oxonic Acid; Pleural Effusion, Malignant; Pyridines; Quality of Life; Tegafur; Uracil | 2006 |
[Efficacy of the combined use of taurine for hyperbilirubinemia caused by UFT therapy after surgery for colonic cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; Female; Humans; Hyperbilirubinemia; Male; Middle Aged; Postoperative Care; Taurine; Tegafur; Uracil | 2006 |
[A case of hepatic metastases of sigmoid colon cancer which completely responded to systemic l-leucovorin/5-FU therapy and oral LV/UFT combination therapy].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Sigmoid Neoplasms; Tegafur; Uracil | 2006 |
[Second-line chemotherapy with pharmacokinetic modulating chemotherapy for unresectable colorectal carcinoma recurrences resistant to 5-FU-based chemotherapy].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronotherapy; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Rectal Neoplasms; Survival Rate; Tegafur; Uracil | 2006 |
[Complete response to CPT-11 and UFT/LV combination therapy in a case with simultaneous multiple lung metastases from colon cancer].
Topics: Adenocarcinoma; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Administration Schedule; Drug Combinations; Female; Humans; Irinotecan; Leucovorin; Leukopenia; Lung Neoplasms; Middle Aged; Neoplasms, Multiple Primary; Neutropenia; Remission Induction; Tegafur; Uracil; Vomiting, Anticipatory | 2006 |
[Advanced rectal cancer in an older patient, in whom metastatic liver lesions were effectively controlled with oral UFT+LV and venous CPT-11 administration--case report].
Topics: Adenocarcinoma; Administration, Oral; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colon, Sigmoid; Colostomy; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intra-Arterial; Irinotecan; Leucovorin; Liver Neoplasms; Male; Omentum; Peritoneal Neoplasms; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2006 |
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Female; Gemcitabine; Humans; Jaundice, Obstructive; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pancreatic Neoplasms; Pyridines; Quality of Life; Remission Induction; Tegafur; Uracil | 2006 |
[Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Rectal Neoplasms; Remission Induction; Retrospective Studies; Survival Rate; Tegafur; Uracil; Vomiting, Anticipatory | 2006 |
[24 hour infusion of CPT-11/oral UFT/LV].
Topics: Administration, Oral; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Infusions, Intravenous; Irinotecan; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Tegafur; Uracil | 2006 |
Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Proportional Hazards Models; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Tegafur; Uracil | 2006 |
[Efficacy of uracil/tegafur (UFT) plus oral Leucovorin (LV) therapy for colorectal cancer in elderly patients].
Topics: Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Diarrhea; Drug Administration Schedule; Drug Combinations; Female; Humans; Leucovorin; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 2006 |
[A case of recurrent gastric cancer with dihydropyrimidine dehydrogenase (DPD) deficiency].
Topics: Adult; Anorexia; Antimetabolites, Antineoplastic; Bone Neoplasms; Cerebral Hemorrhage; Dihydropyrimidine Dehydrogenase Deficiency; Drug Combinations; Fatal Outcome; Humans; Liver Neoplasms; Male; Nausea; Oxonic Acid; Stomach Neoplasms; Tegafur; Uracil | 2006 |
Schedule-dependent therapeutic effects of gemcitabine combined with uracil-tegafur in a human pancreatic cancer xenograft model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Equilibrative Nucleoside Transporter 1; Fluorouracil; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; RNA, Messenger; Tegafur; Uracil; Xenograft Model Antitumor Assays | 2006 |
[A case of advanced esophageal cancer with suspected tracheoesophageal fistula that responded to chemoradiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Radiotherapy Dosage; Remission Induction; Stents; Tegafur; Trachea; Tracheal Stenosis; Tracheoesophageal Fistula; Uracil | 2006 |
[A patient with pancreatic cancer and multiple liver metastases after total pancreatectomy who showed a partial response to combination chemotherapy with gemcitabine and UFT].
Topics: Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Drug Combinations; Gemcitabine; Humans; Liver Neoplasms; Male; Pancreatectomy; Pancreatic Neoplasms; Quality of Life; Remission Induction; Tegafur; Uracil | 2006 |
[Two metastatic colonic cancer patients successfully treated by combination therapy of tegafur/uracil (UFT) and oral Leucovorin].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid; Colonic Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Remission Induction; Tegafur; Uracil | 2006 |
[A case of effective multidisciplinary treatment with hepatic resection for synchronous multiple liver metastases from rectal cancer].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin; Quality of Life; Rectal Neoplasms; Remission Induction; Tegafur; Uracil | 2006 |
[A case of advanced rectal cancer responding to oral UFT and Leucovorin-based preoperative chemoradiation therapy].
Topics: Adenocarcinoma; Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Humans; Leucovorin; Male; Quality of Life; Radiotherapy Dosage; Rectal Neoplasms; Rectum; Tegafur; Uracil | 2006 |
[A long survival case of sigmoid colon cancer patient with initially unresectable hepatic metastases].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Hepatectomy; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Neoadjuvant Therapy; Second-Look Surgery; Sigmoid Neoplasms; Survivors; Tegafur; Uracil | 2007 |
[A case of effective regimen of tegafur and uracil (UFT)/leucovorin (LV) plus irinotecan (CPT-11) for advanced rectal carcinoma with severe pelvic infiltration to be performed curative resection].
Topics: Adenocarcinoma; Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Humans; Irinotecan; Leucovorin; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Pelvic Neoplasms; Quality of Life; Rectal Neoplasms; Tegafur; Uracil | 2007 |
[Superficial bladder cancer with lung metastasis without local invasion: a case report].
Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Doxorubicin; Drug Administration Schedule; Drug Combinations; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Pneumonectomy; Tegafur; Thoracoscopy; Uracil; Urinary Bladder Neoplasms | 2007 |
[Comparison the standard therapies of gastric cancer in Japan with those in the West].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Drug Combinations; Europe; Fluorouracil; Gastrectomy; Humans; Japan; Lymph Node Excision; Mitomycin; Neoplasm Staging; Practice Guidelines as Topic; Stomach Neoplasms; Survival Rate; Tegafur; United States; Uracil | 2007 |
[A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Liver Neoplasms; Male; Neoplasm Staging; Oxonic Acid; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2007 |
[A case of breast metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; Middle Aged; Neoplastic Cells, Circulating; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Uracil | 2007 |
[An elderly case of advanced cervical esophageal cancer successfully treated with UFT after chemoradiotherapy with docetaxel/5-FU/CDDP].
Topics: Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Esophageal Neoplasms; Female; Fluorouracil; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Quality of Health Care; Taxoids; Tegafur; Uracil | 2007 |
[A case of unresectable colon cancer responding to oral leucovorin+oral tegafur/uracil].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Colon, Sigmoid; Combined Modality Therapy; Drug Administration Routes; Drug Combinations; Gastric Bypass; Hepatectomy; Humans; Jejunum; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Palliative Care; Second-Look Surgery; Sigmoid Neoplasms; Tegafur; Uracil | 2007 |
[Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Humans; Kidney Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Nephrectomy; Pneumonectomy; Quality of Life; Remission Induction; Tegafur; Uracil | 2007 |
Pharmacokinetics of gamma-hydroxybutylic acid (GHB) and gamma-butyrolactone (GBL), the anti-angiogenic metabolites of oral fluoropyrimidine UFT, in patients with gastric cancer.
Topics: 4-Butyrolactone; Administration, Oral; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Drug Combinations; Female; Humans; Hydroxybutyrates; Male; Middle Aged; Stomach Neoplasms; Tegafur; Uracil | 2007 |
5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Rats; Rats, Inbred F344; RNA, Neoplasm; Tegafur; Uracil; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2008 |
Immunochemotherapy with PSK and fluoropyrimidines improves long-term prognosis for curatively resected colorectal cancer.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Combined Modality Therapy; Drug Combinations; Female; Floxuridine; Fluorouracil; Humans; Immunotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Proportional Hazards Models; Proteoglycans; Retrospective Studies; Tegafur; Uracil | 2008 |
Health-related quality of life of colorectal cancer patients receiving oral UFT plus leucovorin compared with those with surgery alone.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Chemotherapy, Adjuvant; Chi-Square Distribution; Colectomy; Colorectal Neoplasms; Colostomy; Drug Combinations; Female; Humans; Leucovorin; Longitudinal Studies; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Tegafur; Time Factors; Treatment Outcome; Uracil | 2010 |
[A case of effective chemotherapy using S-1 and CPT-11 following chemoradiotherapy with UFT and Leucovorin for unresectable advanced sigmoid colon cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug Combinations; Humans; Irinotecan; Leucovorin; Male; Oxonic Acid; Sigmoid Neoplasms; Tegafur; Uracil | 2010 |
Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphocyte Count; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Radiotherapy, Adjuvant; Rectal Neoplasms; Retrospective Studies; Survival Rate; Tegafur; Treatment Outcome; Uracil | 2010 |
Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
Topics: Anastrozole; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Combinations; Estrogen Receptor alpha; Estrogens; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Oxonic Acid; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tegafur; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured; Uracil | 2011 |
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Floxuridine; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors; Uracil | 2016 |